Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'dom'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Jovanovic D, Kandic B, Kr... Neka nasa iskustva u lecenju dusevnih bolesnika dietilamidom lizergicn... Vojno-sanit.Pregl. 1960
Uyeno ET Lysergic acid diethylamide and dominance behaviour of the squirrel mon... Arch Int Pharmacodyn 1967
Uyeno ET Lysergic acid diethylamide and sexual dominance behaviour of the male ... Int J Neurospsychiat 1967
Uyeno ET Effects of mescaline and psilocybin on dominance behaviour of the rat Arch Int Pharmacodyn 1967
Newman B, Dihrberg A, Sul... Thin layer chromatography of lysergic acid diethylamide (LSD_, N,N dim... Abstr. Papers, Am. C... 1968
Booij J Vraagstukken rondom de psychotherapie Ned. T. Geneesk. 1968
Snyder SH, Faillace LA, W... DOM STP, a new hallucinogenic drug, and DOET: effects in normal subjec... Am J Psychiatry 1968
Smith DE The Psychotomimetic Amphetamines with Special Reference to DOM (STP) T... Journal of Psychedel... 1969
Malleson N Acute adverse reactions to LSD in clinical and experimental use in the... Brit. J. Psychiat. 1971
Hawks DV The dimensions of drug dependence in the United Kingdom Int. J. Addict. 1971
Wallach MB, Friedman E, G... 2,5-Dimethoxy-4-methylamphetamine (DOM), a neuropharmacological examin... J. Pharmacol. exp. T... 1972
Ronald T. Coutts and Jerr... The Synthesis of Analogs of the Hallucinogen 1-2,5-Dimethoxy-4-methylp... Can. J. Chem. 1973
Marquis WJ, Tilson HA, Re... Effects of amphetamine(A), LSD, psilocybin (P), and DOM on schedule-co... Federation Proceedin... 1973
Cheng HC, Long JP, Barfkn... Cardiovascular effects of 2, 5-dimethoxy-4-methylamphetamine DOM, STP J Pharmacol Exp Ther 1973
Ronald T. Coutts and Jerr... The Synthesis of Some Analogs of the Hallucinogen 1-2,5-Dimethoxy-4-me... Can. J. Chem. 1973
Nichols DE, Barfknecht CF... Potential psychotomimetics. 2. Rigid analogs of 2,5-dimethoxy-4-methyl... J Med Chem 1974
Angrist B, Rotrosen J, Ge... Assessment of Tolerance to the Hallucinogenic Effects of DOM Psychopharmacologia 1974
Srám RJ, Zudova Z, Goetz ... The Mutagenic Effect Of Lysergic Acid Diethylamide. II. Dominant Letha... Mutation Research 1974
Ronald T. Coutts and Jerr... The Synthesis of Four Possible in vitro Metabolites of the Hallucinoge... Can. J. Chem. 1974
Beaton JM, Benington F, B... Stereospecific actions of 2,5-dimethoxy-4-methylamphetamine DOM on col... Br J Pharmacol 1976
Friedman E, Lambert GA, B... 2,5-Dimethoxy-4-methylamphetamine (DOM)- a central component of its ca... Eur J Pharmacol 1978
Silverman PB, Ho BT Stimulus Properties of DOM: Commonality with Other Hallucinogens Psychopharmacology 1978
Brandon JM Failure of indomethacin and d-2-bromolysergic acid diethylamide to mod... J. Endocr. 1978
Glennon RA, Rosecrans JA,... Hallucinogens As A Discriminative Stimuli: Generalizations Of Dom To A... Life Sci. 1979
Shannon HE MDA and DOM: Substituted Amphetamines that do not Produce Amphetamine-... Psychopharmacology 1980
Commissaris RL, Lyness WH... Effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methyla... Federation Proceedin... 1981
Davis EW Out of the vast array of species in the plantkingdom — variously estim... Botanical Museum Lea... 1983
Glennon RA, Young R, Jacy... DOM-Stimulus Generalization to LSD and Other Hallucinogenic Indolealky... European Journal of ... 1983
Mokler DJ, Commissaris R... Naloxone Alters the Effects of LSD, DOM and Quipazine on Operant Behav... Pharmacology Biochem... 1984
Mokler DJ, Rech RH Behavioral Effects of Intracerebroventricular Administration of LSD, D... Pharmacology Biochem... 1984
Adams LM, Geyer MA Effects of DOM and DMT in a proposed animal model of hallucinogenic ac... Prog Neuropsychophar... 1985
Glennon RA, Hauck AE Mechanistic studies on DOM as a discriminative stimulus Pharmacol Biochem Be... 1985
Dimpfel W, Spuler M, Nich... Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting... Psychopharmacology (... 1989
Perez-Reyes M, Burstein S... Antagonism of marihuana effects by indomethacin in humans Life Sci 1991
Screaton GR, Singer M, Ca... Hyperpyrexia and rhabdomyolysis after MDMA ('ecstasy') abuse Lancet 1992
Glennon RA MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethy... Pharmacol Biochem Be... 1993
Aulakh CS, Mazzola-Pomiet... Role of various 5-HT receptor subtypes in mediating neuroendocrine eff... J Pharmacol Exp Ther 1994
Lehmann ED, Thom CH, Crof... Delayed severe rhabdomyolysis after taking 'ecstasy' Postgrad Med J 1995
Volz HP, Kieser M Kava-kava extract WS 1490 versus placebo in anxiety disorders--a rando... Pharmacopsychiatry 1997
Cunningham M Ecstasy-induced rhabdomyolysis and its role in the development of acut... Intensive Crit Care ... 1997
Fiorella D, Helsley S, Ra... Further investigations of the interactions of antipsychotics with the ... Neuropharmacology 1997
Krishnan A, Brown R Plain abdominal radiography in the diagnosis of the 'body packer' J Accid Emerg Med 1999
Akhondzadeh S, Naghavi HR... Passionflower in the treatment of generalized anxiety: a pilot double-... J Clin Pharm Ther 2001
Knoller N, Levi L, Shosha... Dexanabinol (HU-211) in the treatment of severe closed head injury: a ... Crit Care Med 2002
Solomon PR, Adams F, Silv... Ginkgo for memory enhancement: a randomized controlled trial JAMA 2002
Goldberg L, Elliot DL, Ma... Drug testing athletes to prevent substance abuse: background and pilot... J Adolesc Health 2002
Sue YM, Lee YL, Huang JJ Acute hyponatremia, seizure, and rhabdomyolysis after ecstasy use J Toxicol Clin Toxic... 2002
Eckler JR, Chang-Fong J, ... Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabol... Pharmacol Biochem Be... 2003
McCabe SE, Boyd CJ, Young... Mode effects for collecting alcohol and tobacco data among 3rd and 4th... Addict Behav 2005
Scott-Ham M, Burton FC Toxicological findings in cases of alleged drug-facilitated sexual ass... Journal of clinical ... 2005
Padmanabhan R, Hildreth A... A prospective, randomised, controlled study examining binaural beat au... Anaesthesia 2005
Biederman J, Swanson JM, ... Efficacy and safety of modafinil film-coated tablets in children and a... Pediatrics 2005
Safarinejad MR, Hosseini ... Safety and efficacy of tramadol in the treatment of premature ejaculat... J Clin Psychopharmac... 2006
Alatrash G, Majhail NS, P... Rhabdomyolysis after ingestion of 'foxy,' a hallucinogenic tryptamine ... Mayo Clin Proc 2006
Zarate CA, Singh JB, Carl... A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-... Arch Gen Psychiatry 2006
Furey ML, Drevets WC Antidepressant efficacy of the antimuscarinic drug scopolamine: a rand... Arch Gen Psychiatry 2006
Robertson JR, Raab GM, Br... Addressing the efficacy of dihydrocodeine versus methadone as an alter... Addiction 2006
Gray MT Freedom and resistance: the phenomenal will in addiction Nurs Philos 2007
Walsh C Drugs and human rights: private palliatives, sacramental freedoms andc... The International Jo... 2010
Baggott MJ, Siegrist JD, ... Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4... Plos One 2010
Krupitsky E, Nunes EV, Li... Injectable extended-release naltrexone for opioid dependence: a double... Lancet 2011
Mithoefer MC, Wagner MT, ... The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assi... J Psychopharmacol 2011
Petroczi A, Nepusz T, Cro... New non-randomised model to assess the prevalence of discriminating be... Subst Abuse Treat Pr... 2011
Bar-Or D, Salottolo KM, O... A Randomized Double-Blind, Placebo-Controlled Multicenter Study to Eva... Eur Urol 2011
MacLean KA, Johnson MW, G... Mystical experiences occasioned by the hallucinogen psilocybin lead to... J Psychopharmacol 2011
Oehen P, Traber R, Widmer... A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymeth... J Psychopharmacol 2013
Mohamed AD, Lewis CR Modafinil increases the latency of response in the Hayling Sentence Co... PLoS One 2014
Kamour A, James D, Lupton... Patterns of presentation and clinical features of toxicity after repor... Clin Toxicol (Phila) 2014
Savage KM, Stough CK, Byr... Kava for the treatment of generalised anxiety disorder (K-GAD): study ... Trials 2015
O'Connor AD, Padilla-Jone... Prevalence of Rhabdomyolysis in Sympathomimetic Toxicity: a Comparison... J Med Toxicol 2015
Flindall I, Leff DR, Good... Structured cues or modafinil for fatigue amelioration in clinicians? A... Surgery 2015
Racz J, Csak R, Toth KT, ... Veni, vidi, vici: The appearance and dominance of new psychoactive sub... Drug Alcohol Depend 2016
Hope VD, Cullen KJ, Smith... Is the recent emergence of mephedrone injecting in the United Kingdom ... Euro Surveill 2016
Kalasho A, Vibe Nielsen S 5-MeO-DALT; a novel designer drug on the market causing acute delirium... Acta Anaesthesiol Sc... 2016
Grunebaum MF, Galfalvy HC... Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression:... Am J Psychiatry 2017
Danforth AL, Grob CS, Str... Reduction in social anxiety after MDMA-assisted psychotherapy with aut... Psychopharmacology (... 2018
Uenoyama R, Miyazaki T, H... The characteristic response of domestic cats to plant iridoids allows ... Sci Adv 2021